Journal of Diabetes Research / 2015 / Article / Tab 1

Research Article

Alteration of Mevalonate Pathway in Proliferated Vascular Smooth Muscle from Diabetic Mice: Possible Role in High-Glucose-Induced Atherogenic Process

Table 1

Glucose and lipid analysis at 0-, 8-, and 16-week diabetic duration in BALB/c mice.

WeekFBG (mM)TC (mM)HDL-C (mM)LDL-C (mM)TG (mM)

Control mice
 0 ()7.82 ± 0.701.82 ± 0.070.93 ± 0.060.48 ± 0.061.31 ± 0.05
 8 ()7.66 ± 0.621.88 ± 0.070.86 ± 0.070.44 ± 0.061.30 ± 0.05
 16 ()8.40 ± 0.611.90 ± 0.080.93 ± 0.060.45 ± 0.061.25 ± 0.05
Diabetic mice
 0 ()8.20 ± 0.631.93 ± 0.090.85 ± 0.060.47 ± 0.051.26 ± 0.06
 8 ()19.54 ± 1.39#1.91 ± 0.080.84 ± 0.050.48 ± 0.071.35 ± 0.06
 16 ()21.04 ± 1.42#1.96 ± 0.080.77 ± 0.060.53 ± 0.071.40 ± 0.05

Data expressed as mean ± SEM.
versus age-matched control mice.
FBG, fasting blood glucose; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride.